Rapid anti-tumor effects of gelatin sponge/nano-β-TCP construct on SKOV-3 human ovarian cancer cells in vitro

Author:

Xing Ma 1,Wu Xiao-Ming2,Duan Hai-Xia3,Tao Fu 4,Ma Xiang-Dong5

Affiliation:

1. Department of Orthopaedics, The First Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an 710061, P.R. China

2. Department of Biomedical Engineering, The Fourth Military Medical University, Xi'an 710032, P.R. China

3. Department of Gynaecology and Obstetrics, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, P.R. China

4. School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, P.R. China

5. Department of Gynaecology and Obstetrics, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, P.R. China,

Abstract

Nanosized β-tricalcium phosphate (nano-β-TCP) particles were synthesized and characterized by transmission electron microscopy and X-ray diffraction. A surface coating was used to fabricate a medical absorbable gelatin sponge (GS) with nano-β-TCP biocomposite (GSN). The nano-β-TCP particles were ~150 nm in diameter and GSN was highly porous with pore diameter of ~200 μm. Modification via nano-β-TCP coating endowed the biocomposite with actual inhibitory effects on human ovarian cancer SKOV-3 cells. The systematic in vitro evaluations including ultrastructural observation, MTT assay, cell cycle analysis, apoptosis detection, and assessment of proliferating cell nuclear antigen (PCNA) expression data confirm that rapid internalization of nano-β-TCP, cell growth inhibition, G1/S phase cell cycle arrest, apoptosis, and suppression of PCNA expression play important roles in the rapid anti-tumor effects of GNS on SKOV-3 cells. Currently, in vitro and in vivo research work are in progress, including special anti-neoplastic drug delivery and synergistic effects of GSN and chemotherapeutic agents.

Publisher

SAGE Publications

Subject

Materials Chemistry,Polymers and Plastics,Biomaterials,Bioengineering

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3